000 | 01564 a2200409 4500 | ||
---|---|---|---|
005 | 20250513050502.0 | ||
264 | 0 | _c19950407 | |
008 | 199504s 0 0 eng d | ||
022 | _a0820-3946 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSutter, M C | |
245 | 0 | 0 |
_aLessons for atherosclerosis research from tuberculosis and peptic ulcer. _h[electronic resource] |
260 |
_bCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne _cMar 1995 |
||
300 |
_a667-70 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aArteriosclerosis _xepidemiology |
650 | 0 | 4 | _aChickens |
650 | 0 | 4 |
_aChlamydia Infections _xcomplications |
650 | 0 | 4 |
_aChlamydophila pneumoniae _xisolation & purification |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aCytomegalovirus _xisolation & purification |
650 | 0 | 4 |
_aCytomegalovirus Infections _xcomplications |
650 | 0 | 4 |
_aDuodenal Ulcer _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHelicobacter Infections _xcomplications |
650 | 0 | 4 |
_aHelicobacter pylori _xisolation & purification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMarek Disease _xcomplications |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xisolation & purification |
650 | 0 | 4 |
_aPeptic Ulcer _xdrug therapy |
650 | 0 | 4 | _aResearch |
650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
773 | 0 |
_tCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne _gvol. 152 _gno. 5 _gp. 667-70 |
|
999 |
_c7881566 _d7881566 |